The Medical Futurist

JUNE 21, 2025

Treating less serious ailments gets faster, more targeted and more efficient, while the means for curing more serious and life-altering illnesses improve. Their research showed promising results for lab rats, and they plan to carry out the first human trials in the second half of 2017 and gather preliminary results during 2018.

Diabetes 105

Diabetes Patient-Centered IT Patients 105

FDA Law

AUGUST 4, 2022

Pfizer manufactures tafamidis, a breakthrough treatment for a rare, progressive heart condition known as transthyretin amyloid cardiomyopathy. Most of these cases have settled out of court (see, for example, Actelion Pharmaceuticals , 2018; Astellas Pharma and Amgen , 2019; Gilead Sciences , 2020). Background.

Manufacturing 98

Manufacturing Medical Government IT 98

FDA Law

OCTOBER 25, 2021

The regulatory uncertainty has ill?befitted It was published approximately three years after the December 7, 2018 release of the proposed rule (see blog post on the proposed rule here ). In the PMA context, the statute permits FDA to withhold approval if manufacturing facilities do not conform to QSR requirements. Part 860.

Manufacturing 52

Manufacturing Government Specialization IT 52

GeriPal

MARCH 24, 2022

Then listen to these prior podcasts with Sean Morrison and Rebecca Sudore about this issue, and we recently discussed differences between Advance Care Planning and Serious Illness Communication with Juliet Jacobsen and Rachelle Bernacki. . 2018 Systematic Review of Systematic Reviews on ACP. Where does POLST fit in with this debate?

Illness 72

Illness IT Healthcare Patient-Centered 72